OCT 21, 2020 11:00 AM PDT

CNS's immune cells - Microglia are involved in the exacerbation of MS

WRITTEN BY: Heba El Wassef

Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where the immune system attacks the myelin sheath that covers the nerve fibers and causes impairment in the communication between the brain and the body.

Some of its symptoms include tremors, numbness, or weakness in limbs, blurry vision, and slurred speech.

MS usually onset between 20- 30 years of age and it worsens over time. It is usually presented as attacks that progress and inevitably leads to a gradual functional loss.

“Despite these important breakthroughs, the disease generally worsens when the patient has had it for 10 to 20 years,” says Maja Jagodic, docent of experimental medicine at the Department of Clinical Neuroscience and the Centre for Molecular Medicine, Karolinska Institutet. “There is currently only one, recently approved, treatment for what is called the secondary progressive phase. The mechanisms behind this progressive phase require more research.”

Recently Researchers at Karolinska Institutet published a study at Science Immunology that discovered that Microglia- the CNS’s immune cells have a role in the progression of the disease.

The microglia is responsible for clearing the remains of damaged cells as myelin, an autophagy gene Atg7 is involved in this process as well. Autophagy is a process of programmed cell death done normally by the cells and microglia use it in the clearance process.

Researchers found that when the autophage gene Atg7 is removed in mice, this reduced the ability of microglia to break down and clear away the tissue remains when inflammation occurs. The microglia in aged mice resembles the ones in young mice that lack that gene in the reduction of the process which leads to the accumulation of tissue remains and progression of the disease.

Credit: Mayo Clinic

This is not the only outcome of the study, they also showed how this process can be reversed.

Trehalose a sugar derived from plants and fungi can be used as a treatment  to increase the myelin clearance and decrease the progression of MS

“The plant and fungi-derived sugar Trehalose restores the functional breakdown of myelin residues, stops the progression and leads to recovery from MS-like disease.” says doctoral student Rasmus Berglund. “By enhancing this process we hope one day to be able to treat and prevent age-related aspects of neuroinflammatory conditions.”

To understand more about multiple sclerosis, watch the video below.

 

Sources: Science DailyKarolinska Institutet, Mayo Clinic

 

 

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
OCT 21, 2020
Drug Discovery & Development
Experimental Vaccine Shows Promise in Halting Alzheimer's
OCT 21, 2020
Experimental Vaccine Shows Promise in Halting Alzheimer's
In a preclinical study, researchers from the Univerity of South Florida have found that a vaccine that targets neurotoxi ...
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
DEC 15, 2020
Immunology
Immunity-Boosting: Is It Real?
DEC 15, 2020
Immunity-Boosting: Is It Real?
The question everyone tries to find an answer to in the winter season is how can we improve our immunity to fight any in ...
JAN 13, 2021
Immunology
Antibodies Gain the Upper Hand Against Sly Tumors
JAN 13, 2021
Antibodies Gain the Upper Hand Against Sly Tumors
Tumors use ingenious approaches to stay just out of reach of immune cells on patrol and avoid detection. Indeed, cancer ...
FEB 03, 2021
Immunology
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
FEB 03, 2021
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
Researchers are still studying how long a person can stay immune against COVID-19 following infection. A new study by a ...
Loading Comments...